Vireo Growth (VREOF) FCF Margin (2020 - 2026)

Vireo Growth (VREOF) reported FCF Margin of 1.04% for Q1 2026, up 1940.0% on a YoY basis from 0.05% in Q1 2025, and down 87.69% sequentially from 8.41% in Q4 2025.

Vireo Growth (VREOF) FCF Margin (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of FCF Margin data on file, last reported at 1.04% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 1940.0% year-over-year to 1.04%; the trailing twelve-month figure through Mar 2026 stood at 5.43% (up 1896.0% YoY), and the FY2025 full-year result was 9.16%, up 1291.0% from the prior year.
  • FCF Margin slipped to 1.04% in Q1 2026, from 8.41% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 8.41% in Q4 2025 to a low of 57.13% in Q1 2022.
  • A 5-year average of 17.54% and a median of 17.59% in 2025 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin jumped 10796 bps in 2022 and slumped 3580 bps in 2024, its largest moves.
  • Tracing VREOF's FCF Margin over 5 years: stood at 35.4% in 2022, then soared by 67 bps to 11.55% in 2023, then sank by 217 bps to 36.62% in 2024, then jumped by 123 bps to 8.41% in 2025, then slumped by 88 bps to 1.04% in 2026.
  • Business Quant data shows VREOF's FCF Margin at 1.04% in Q1 2026, 8.41% in Q4 2025, and 22.31% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -5.22%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 12.86%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5.35%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 46.54%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9.93%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 17.73%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.77%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 1.04%

Historic Data

Download Data
DateValue
Mar 31, 2026 1.04%
Dec 31, 2025 8.41%
Sep 30, 2025 -22.31%
Jun 30, 2025 -17.59%
Mar 31, 2025 -18.37%
Dec 31, 2024 -36.62%
Sep 30, 2024 -29.71%
Jun 30, 2024 -12.74%
Mar 31, 2024 -8.68%
Dec 31, 2023 -11.55%
Sep 30, 2023 6.09%
Jun 30, 2023 -3.20%
Mar 31, 2023 -20.92%
Dec 31, 2022 -35.40%
Sep 30, 2022 -16.59%
Jun 30, 2022 -22.91%
Mar 31, 2022 -57.13%
Dec 31, 2021 -82.04%
Sep 30, 2021 -66.11%
Jun 30, 2021 -130.86%